07
May

Menlo Park, CA’s Corcept watched its shares roughly halve Wednesday morning after it pulled the plug on a late-stage trial of an investigational depression treatment.

…read more

Source: Corcept tanks as depression drug comes up short in Phase III

    

0 No comments